Savara (SVRA) Debt Ratio (2015 - 2026)
Savara's (SVRA) quarterly Debt Ratio came in at 0.14 in Q1 2026, down 13.02% year-on-year from 0.16 in Q1 2025, and up 14.95% on a QoQ basis from 0.12 in Q4 2025.
Savara (SVRA) Debt Ratio (2015 - 2026) Analysis & Trends
Savara (SVRA) has 12 years of Debt Ratio data on file, last reported at 0.14 in Q1 2026.
- On a quarterly basis, Debt Ratio fell 13.02% year-over-year to 0.14 in Q1 2026; TTM through Mar 2026 was 0.14, a 13.02% decrease from a year earlier, with the FY2025 full-year figure at 0.12, down 5.63% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.14, up from 0.12 in the prior quarter.
- Over the last five years, Debt Ratio for SVRA reached as high as 0.22 in Q2 2023 and fell as low as 0.11 in Q3 2024.
- Historically, Debt Ratio has averaged 0.16 across 5 years, with a median of 0.17 in 2022.
- Across the five-year window, Debt Ratio retreated 22.97% in 2024 and jumped 90.07% in 2025, its largest moves.
- Year by year, Debt Ratio stood at 0.19 in 2022, then decreased by 20.47% to 0.15 in 2023, then slipped by 15.73% to 0.13 in 2024, then declined by 5.63% to 0.12 in 2025, then climbed by 14.95% to 0.14 in 2026.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.14 in Q1 2026, 0.12 in Q4 2025, and 0.21 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 1.41 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.11 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.05 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | 0.14 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.14 |
| Dec 31, 2025 | 0.12 |
| Sep 30, 2025 | 0.21 |
| Jun 30, 2025 | 0.18 |
| Mar 31, 2025 | 0.16 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | 0.11 |
| Jun 30, 2024 | 0.19 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | 0.15 |
| Sep 30, 2023 | 0.14 |
| Jun 30, 2023 | 0.22 |
| Mar 31, 2023 | 0.20 |
| Dec 31, 2022 | 0.19 |
| Sep 30, 2022 | 0.18 |
| Jun 30, 2022 | 0.17 |
| Mar 31, 2022 | 0.16 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.14 |
| Jun 30, 2021 | 0.13 |